Dr Reddys Laboratories informs about dividend updates

09 May 2025 Evaluate
Dr Reddys Laboratories has informed that the Board of Directors of the Company, at their meeting held on May 9, 2025, has transacted and approved the following businesses: Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2025. In terms of the above, they are enclosing: 1. Audited Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, as per the International Financial Reporting Standards (IFRS) as issued by International Accounting Standards Board (IASB); Press Release on Financial Results of the Company for the above period; Audited Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, as per Indian Accounting Standards; Audited Standalone Financial Results of the Company for the quarter and year ended March 31, 2025, as per Indian Accounting Standards.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1274.50 -2.50 (-0.20%)
05-Dec-2025 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.50
Dr. Reddys Lab 1274.50
Cipla 1520.00
Zydus Lifesciences 930.75
Lupin 2098.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×